Kawasaki Disease in an Infant Following Immunisation with Hepatitis B Vaccine

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2003 Dec 17

PMID 14677029

Citations 13

Authors

Dan Miron

Daniel Fink

Philip J Hashkes

Affiliations

Soon will be listed here.

Abstract

The known association between hepatitis B and vasculitis has been reported in rare cases in adults after hepatitis B vaccination. We here describe a 35-day-old infant who developed Kawasaki disease 1 day after receiving his second dose of hepatitis B vaccine. Although extremely rare, this possible side effect should be noted and further investigated.

Citing Articles

VAERS Vasculitis Adverse Events Retrospective Study: Etiology Model of Immune Complexes Activating Fc Receptors in Kawasaki Disease and Multisystem Inflammatory Syndromes.

Ricke D, Smith N Life (Basel). 2024; 14(3).

PMID: 38541678 PMC: 10971466. DOI: 10.3390/life14030353.

Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines.

Kamidani S, Panagiotakopoulos L, Licata C, Daley M, Yih W, Zerbo O Pediatrics. 2022; 150(6).

PMID: 36349537 PMC: 9724171. DOI: 10.1542/peds.2022-058789.

Research trends on causes of Kawasaki disease in the COVID-19 era: focus on viral infections.

Lee Y Clin Exp Pediatr. 2022; 66(1):1-11.

PMID: 35760413 PMC: 9815937. DOI: 10.3345/cep.2022.00150.

Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.

Chang L, Yang H, Lin T, Yang K Front Pediatr. 2021; 9:697632.

PMID: 34350146 PMC: 8326331. DOI: 10.3389/fped.2021.697632.

Pan-vasculitis and fulminant hepatitis following routine vaccination at the age of 4 months.

Awad M, El-Hawary A, Sawah G, Nasef N Clin Exp Vaccine Res. 2021; 10(1):78-80.

PMID: 33628757 PMC: 7892943. DOI: 10.7774/cevr.2021.10.1.78.

References

Cockwell P, Allen M, Page R . Vasculitis related to hepatitis B vaccine. BMJ. 1990; 301(6763):1281. PMC: 1664388. DOI: 10.1136/bmj.301.6763.1281-b. View

Rosenfeld E, Corydon K, Shulman S . Kawasaki disease in infants less than one year of age. J Pediatr. 1995; 126(4):524-9. DOI: 10.1016/s0022-3476(95)70344-6. View

Kerleau J, Levesque H, Lair G, Lecomte F, CARRARA O, Courtois H . [Is hepatitis B vaccination a new cause of necrotizing vasculitis?]. Rev Med Interne. 1997; 18(6):491-2. DOI: 10.1016/s0248-8663(97)80624-8. View

Tsuchida S, Yamanaka T, Tsuchida R, Nakamura Y, Yashiro M, Yanagawa H . Epidemiology of infant Kawasaki disease with a report of the youngest neonatal case ever reported in Japan. Acta Paediatr. 1996; 85(8):995-7. DOI: 10.1111/j.1651-2227.1996.tb14201.x. View

Leung D, Meissner H, Shulman S, Mason W, Gerber M, Glode M . Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 2002; 140(6):742-6. DOI: 10.1067/mpd.2002.123664. View

Mader R, Narendran A, Lewtas J, Bykerk V, Goodman R, Dickson J . Systemic vasculitis following influenza vaccination--report of 3 cases and literature review. J Rheumatol. 1993; 20(8):1429-31. View

Viallard J, Boiron J, Parrens M, Moreau J, Ranchin V, Reiffers J . Severe pancytopenia triggered by recombinant hepatitis B vaccine. Br J Haematol. 2000; 110(1):230-3. DOI: 10.1046/j.1365-2141.2000.02171.x. View

Vanoli M, Gambini D, Scorza R . A case of Churg-Strauss vasculitis after hepatitis B vaccination. Ann Rheum Dis. 1998; 57(4):256-7. PMC: 1752586. DOI: 10.1136/ard.57.4.256. View

Zaas A, Scheel P, Venbrux A, Hellmann D . Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases. J Rheumatol. 2001; 28(5):1116-20. View

10.

Le Hello C, Cohen P, Bousser M, Letellier P, Guillevin L . Suspected hepatitis B vaccination related vasculitis. J Rheumatol. 1999; 26(1):191-4. View

11.

Halle O, Neau D, Monlun E, Rullier E, Longy-Boursier M, Le Bras M . [Peritoneal tuberculosis: late complication of BCG treatment for bladder carcinoma]. Rev Med Interne. 1996; 17(3):265-6. DOI: 10.1016/0248-8663(96)81257-4. View

12.

Koren G, Lavi S, Rose V, Rowe R . Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr. 1986; 108(3):388-92. DOI: 10.1016/s0022-3476(86)80878-2. View

13.

. Erythema nodosum and Takayasu's arteritis after immunization with plasma derived hepatitis B vaccine. J Rheumatol. 1993; 20(8):1417-8. View

14.

Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O . Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore). 1995; 74(5):238-53. DOI: 10.1097/00005792-199509000-00002. View

15.

Allen M, Cockwell P, Page R . Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax. 1993; 48(5):580-1. PMC: 464532. DOI: 10.1136/thx.48.5.580. View

16.

de Keyser F, Naeyaert J, Hindryckx P, Elewaut D, Verplancke P, Peene I . Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol. 2000; 18(1):81-5. View

17.

Drucker Y, Prayson R, Bagg A, Calabrese L . Lymphocytic vasculitis presenting as diffuse subcutaneous edema after hepatitis B virus vaccine. J Clin Rheumatol. 2008; 3(3):158-61. DOI: 10.1097/00124743-199706000-00010. View

18.

Devin F, Roques G, Disdier P, Rodor F, Weiller P . Occlusion of central retinal vein after hepatitis B vaccination. Lancet. 1996; 347(9015):1626. DOI: 10.1016/s0140-6736(96)91112-5. View

19.

Gocke D, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian C . Association between polyarteritis and Australia antigen. Lancet. 1970; 2(7684):1149-53. DOI: 10.1016/s0140-6736(70)90339-9. View

20.

Mathieu E, Fain O, Krivitzky A . Cryoglobulinemia after hepatitis B vaccination. N Engl J Med. 1996; 335(5):355. DOI: 10.1056/nejm199608013350516. View